AMRS Synthetic BIO Industry

25 paź 2021

Not technical analysis, long term play with stock and leaps into 2023, clean beauty leader. Huge upside with large risk, revenue is exploding, leader in the development and commercialization of molecules by fermentation. Not investment advice.

15 lis 2021

Uwaga

terrible earnings and this thing tanked, had a stop loss at 13.50 and bought back in and acquired some 2024 leaps

4 gru 2021

Uwaga

added another leap on friday to average down, long term play, this company could be a game changer in synthetic bio. Just completed a financing that was over subscribed and worked out to be 16.00 per share so some big money believe in this stock. My leaps are all at 10.00, looking for this to be a 10 bagger